Where have you been all year long. This stock has been a loser all year long. Two many negative events (lawsuits and FDA audits Utah) do not help this stock. Competition is building in the THV market and EW THV valve is an early design and the competition such as Jena Valve has a valve that can be positioned and repositioned if required to prevent blocking of the coronary ostia. They have no Mitral THV valve offering and Sorin and 4 other companies are building Mitral THV valves. There is also a company developing a ring repair product that can be implanted via catheter. EW is facing stiff competition.